While today’s drugs help the majority of people with breast cancer survive for years, many who are treated eventually develop Type 2 diabetes, often years after treatment ends. A recent journal publication by a researcher at the University of Oklahoma College of Medicine at OU Health Sciences sheds light on the link between the two diseases and raises awareness for patients and physicians alike.